syndrome of blood deficiency 中文意思是什麼

syndrome of blood deficiency 解釋
血虛證
  • syndrome : n. 1. 【醫學】綜合癥,癥候群。2. (某一事物的)全部特徵;特徵群;(具有某種共同性的不同事物的)集合。
  • of : OF =Old French 古法語。
  • blood : n 1 血,血液;生命液。2 血族,血統;種族;家族(關系);家世;門第;名門,門閥; 〈the blood〉 貴...
  • deficiency : n. 1. 缺乏,不足,短缺。2. 缺陷。3. 不足額;虧空。
  1. Quantiative analysis on relationship between deficiency of qi and blood in chronic fatigue syndrome

    慢性疲勞綜合征氣虛與血虛病機關系的定量分析
  2. Generally speaking, red complexion indicates heat syndromes ; white complexion indicates cold and deficiency syndrome ; yellow complexion deficiency and dampness syndromes ; blue complexion suggests pain and cold syndrome, blood stasis and convulsion ; and black complexion hints deficiency of the kidney, blood stasis and fluid retention

    總的來說,色紅提示熱證;色白提示寒證和虛證;黃色提示虛證和濕證;青色提示痛證、寒證、血瘀和痙證;黑色提示腎虛、血瘀和水液停滯。
  3. Study on blood stasis syndrome with the kidney - deficiency of diabetes pedigree

    腎虛糖尿病家系中的血瘀證研究
  4. An exploration on the relationship between polycystic ovary syndrome and deficiency of kidney and blood stasis

    多囊卵巢綜合征與腎虛血瘀關系淺探
  5. It is argued that chronic atrophic gastritis is caused by spleen - stomach deficiency and heat, dampness and blood - stasis ; it treatment concentrates on nourishing spleen and stomach, regulating qi activity, and combination of disease and syndrome

    認為慢性萎縮性胃炎是以脾胃虛弱為本,熱、濕、瘀為標的本虛標實之疾;治療以扶正祛邪、協調升降、 ?理氣機為大法,在辨證論治為主的基礎上注重與辨病、辨癥相結合。
  6. Results : the scores of liver syndrome, kidney syndrome, yin deficiency, qi deficiency as well as blood stasis were the highest in eh patients with early renal damage, and they were significantly higher than those of eh patients without ear1 renal damage ( p < 0. 01 )

    結果:原發性高血壓早期腎損害患者以肝、腎證候及陰虛、氣虛、血瘀證候積分最高,明顯高於無腎損害的原發性高血壓患者( p < 0 . 01 ) 。
  7. Methods according to clinical manifestations, cases acre classified into 5 kinds of syndromes : hyperactivity of liver yang syndrome ; qi stagnation and blood stasis syndrone ; heat scorching blood vessels syndrome ; deficiency of the heart and spleen syndrome

    方法:根據臨床表現分為:肝陽上亢證;陰虛火旺證;氣滯血瘀證;熱灼血絡證;心脾兩虛證5個證型。
  8. Conclusion hdp has definite effect for the treatment of ap due to chd classified as qi - deficiency and blood - stasis syndrome, having no toxic and side effects

    結論黃芪丹參滴丸治療冠心病心絞痛(氣虛血瘀證)療效確切,未發現毒副作用。
  9. Influences of qi deficiency and qi stagnation in the pathogenesis of coronary heart disease with heart - blood stagnation syndrome

    溫病熱瘀證的病機及分期證治探討
  10. Treatment of senile hypertension with blood - stasis kidney - deficiency syndrome by bushen huoxue instant granules : a clinical observation of 90 cases

    補腎活血沖劑治療老年高血壓病腎虛血瘀證90例療效觀察
  11. Clinical reaearch on syndrome due to deficiency of qi and yin combined to blood stasis of chest or heart pain treated by shuxin pills

    舒心丸治療胸痹氣陰兩虛兼血瘀證的臨床研究
  12. The analytical results showed that the most common appeared syndrome was spleen deficiency, followed by kidney deficiency, deficiency of both qi and blood, dampness, nourishing kidney, regulating stomach, expelling dampness herbs were commonly used

    根據報道的文獻數量和病例數量,證型以脾虛證最多見,其餘包括腎虛證、氣血兩虛證、濕證、瘀毒證;臨床用藥以健脾益氣、清熱解毒、活血化瘀、益腎、和胃、祛濕中藥最常用。
  13. Treatment of coronary heart disease with qi - deficiency and blood - stasis syndrome with shenqixiongtongmai powder : a report of 32 cases

    參芪芎通脈散治療冠心病氣虛血瘀證32例
  14. Experimental study on multilateral establishment of animal model of the qi - deficiency and blood stasis syndrome of cerebral ischemia in rat

    多因素復合製作氣虛血瘀證腦缺血動物模型的實驗研究
  15. Objective to evaluate the therapeutic effect and safety of huangqi danshen drop pill ( hdp ) for angina pectoris ( ap ) due to coronary heart disease ( chd ) classified as qi - deficiency and blood - stasis syndrome

    摘要目的評價黃芪丹參滴丸治療冠心病心絞痛(氣虛血瘀證)的臨床療效和安全性。
  16. Methods k multi - center, randomized, double - blind, double - simulation, positive - controlled, parallel group trial was adopted 209 cases of ap due to chd classified as qi - deficiency and blood - stasis syndrome were enrolled in this study : 104 in hdp group and 105 in yangxinshi tablets group

    方法採用隨機、雙盲雙模擬、陽性藥平行對照、多中心臨床研究方法,將209例受試者分試驗組104例(黃芪丹參滴丸) ,對照組105例(養心氏片) 。
分享友人